#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	4106	16S	1529	1529	99.87	16S.l15.c4.ctg.1	2432	501.9	0	.	n	.	0	G1207A	SNP	1207	1207	G	1599	1599	A	589	A,C,G	507,3,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	4106	16S	1529	1529	99.87	16S.l15.c4.ctg.1	2432	501.9	0	.	n	.	0	C1450T	SNP	1450	1450	C	1842	1842	T	627	T	549	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	4106	16S	1529	1529	99.87	16S.l15.c4.ctg.1	2432	501.9	1	SNP	n	C1184T	0	.	.	1184	1184	C	1576	1576	C	595	C,T,A	512,1,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	4106	16S	1529	1529	99.87	16S.l15.c4.ctg.1	2432	501.9	0	HET	.	.	.	C207T	.	207	207	C	599	599	C	580	C,T	405,92	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	6486	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3915	497.1	0	.	n	.	0	G1337A	SNP	1337	1337	G	1846	1846	A	586	A,G	516,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	6486	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3915	497.1	0	.	n	.	0	T1971C	SNP	1971	1971	T	2480	2480	C	601	C,T	514,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	6486	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3915	497.1	1	SNP	n	A2045G	0	.	.	2045	2045	A	2554	2554	A	628	A	532	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	6486	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3915	497.1	1	SNP	n	C2597T	0	.	.	2597	2597	C	3106	3106	C	590	C	512	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_F_01537c	folP.WHO_F_01537c	1	1	539	616	folP	852	852	99.77	folP.l15.c17.ctg.1	1812	101.8	0	.	p	.	0	D71H	NONSYN	211	213	GAT	656	658	CAT	134;134;133	C;A;T	118;115;111	.	.
folP.WHO_F_01537c	folP.WHO_F_01537c	1	1	539	616	folP	852	852	99.77	folP.l15.c17.ctg.1	1812	101.8	0	.	p	.	0	A204V	NONSYN	610	612	GCA	1055	1057	GTA	140;141;142	G;T;A	132;132;132	.	.
folP.WHO_F_01537c	folP.WHO_F_01537c	1	1	539	616	folP	852	852	99.77	folP.l15.c17.ctg.1	1812	101.8	1	SNP	p	R228S	0	.	.	682	684	CGC	1127	1129	CGC	143;144;144	C;G;C	129;128;124	folP.WHO_F_01537c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	1294	gyrA	2751	2751	99.82	gyrA.l15.c4.ctg.1	3753	103.5	0	.	p	.	0	M250I	NONSYN	748	750	ATG	1267	1269	ATA	95;95;96	A;T;A	82;84;83	.	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	1294	gyrA	2751	2751	99.82	gyrA.l15.c4.ctg.1	3753	103.5	1	SNP	p	S91F	0	.	.	271	273	TCC	790	792	TCC	125;125;124	T;C;C	112;114;112	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	1294	gyrA	2751	2751	99.82	gyrA.l15.c4.ctg.1	3753	103.5	1	SNP	p	D95G	0	.	.	283	285	GAC	802	804	GAC	122;120;120	G;A;C	110;110;107	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	1294	gyrA	2751	2751	99.82	gyrA.l15.c4.ctg.1	3753	103.5	1	SNP	p	D95N	0	.	.	283	285	GAC	802	804	GAC	122;120;120	G;A;C	110;110;107	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_L_00489c	mtrR.WHO_L_00489c	1	1	531	518	mtrR	633	633	99.68	mtrR.l6.c17.ctg.1	1579	98.1	0	.	p	.	0	W136trunc	TRUNC	406	406	T	899	899	T	146	T	125	.	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	332	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	1152	86.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	1208	parC	2304	2304	99.74	parC.l6.c17.ctg.1	3321	109.1	0	.	p	.	0	I384V	NONSYN	1150	1152	ATC	1664	1666	GTC	132;132;132	G;T;C	106;108;105	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	1208	parC	2304	2304	99.74	parC.l6.c17.ctg.1	3321	109.1	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1817	1819	GCA	146;145;145	G;C;A	123;124;126	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	1208	parC	2304	2304	99.74	parC.l6.c17.ctg.1	3321	109.1	0	.	p	.	0	V596I	NONSYN	1786	1788	GTT	2300	2302	ATT	128;128;127	A;T;T	111;107;108	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	1208	parC	2304	2304	99.74	parC.l6.c17.ctg.1	3321	109.1	1	SNP	p	D86N	0	.	.	256	258	GAC	770	772	GAC	149;147;148	G;A;C	130;129;132	parC.WHO_M_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	1208	parC	2304	2304	99.74	parC.l6.c17.ctg.1	3321	109.1	1	SNP	p	S87W	0	.	.	259	261	AGT	773	775	AGT	147;147;146	A;G;T	126;131;128	parC.WHO_M_00204c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	1208	parC	2304	2304	99.74	parC.l6.c17.ctg.1	3321	109.1	1	SNP	p	S87R	0	.	.	259	261	AGT	773	775	AGT	147;147;146	A;G;T	126;131;128	parC.WHO_M_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	1208	parC	2304	2304	99.74	parC.l6.c17.ctg.1	3321	109.1	1	SNP	p	S87I	0	.	.	259	261	AGT	773	775	AGT	147;147;146	A;G;T	126;131;128	parC.WHO_M_00204c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	1208	parC	2304	2304	99.74	parC.l6.c17.ctg.1	3321	109.1	1	SNP	p	S88P	0	.	.	262	264	TCC	776	778	TCC	147;150;150	T,G;C;C	126,1;131;131	parC.WHO_M_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	1060	parE	1986	1986	99.95	parE.l6.c17.ctg.1	2941	107.9	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1720	1722	GGC	135;133;132	G;G;C,A	114;118;115,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.1.001	penA.1.001	1	1	27	1020	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2589	117.5	1	SNP	p	A311V	0	.	.	931	933	GCA	1350	1352	GCA	154;152;152	G;C;A	132;133;133	penA.1.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.1.001	penA.1.001	1	1	27	1020	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2589	117.5	1	SNP	p	I312M	0	.	.	934	936	ATC	1353	1355	ATC	152;152;152	A;T;C	133;130;133	penA.1.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.1.001	penA.1.001	1	1	27	1020	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2589	117.5	1	SNP	p	V316P	0	.	.	946	948	GTG	1365	1367	GTG	156;155;156	G;T;G	136;134;137	penA.1.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.1.001	penA.1.001	1	1	27	1020	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2589	117.5	1	SNP	p	V316T	0	.	.	946	948	GTG	1365	1367	GTG	156;155;156	G;T;G	136;134;137	penA.1.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.1.001	penA.1.001	1	1	27	1020	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2589	117.5	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1869	1871	ACC	128;127;127	A,C;C;C	116,1;115;116	penA.1.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.1.001	penA.1.001	1	1	27	1020	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2589	117.5	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1923	1925	GCG	123;122;122	G;C;G	105;102;100	penA.1.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.1.001	penA.1.001	1	1	27	1020	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2589	117.5	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1923	1925	GCG	123;122;122	G;C;G	105;102;100	penA.1.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.1.001	penA.1.001	1	1	27	1020	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2589	117.5	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2046	2048	GGC	120;121;121	G;G;C	99;106;107	penA.1.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.1.001	penA.1.001	1	1	27	1020	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2589	117.5	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2055	2057	GGC	119;119;117	G;G;C	96;102;98	penA.1.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.1.001	penA.1.001	1	1	27	1020	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2589	117.5	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2073	2075	CCG	117;117;117	C,G,T;C;G,C	95,2,1;104;94,1	penA.1.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	1388	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3357	124.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	604	porA	1146	1146	99.83	porA.l15.c4.ctg.1	2159	83.8	0	.	p	.	0	M83fs	FSHIFT	247	247	A	745	745	C	99	C	87	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	78	porB1a	984	181	90.27	porB1a.l6.c4.ctg.2	394	5.3	0	.	p	.	0	H217N	NONSYN	649	651	CAT	238	240	AAT	5;5;5	A;A;T	5;5;5	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	78	porB1a	984	181	90.27	porB1a.l6.c4.ctg.2	394	5.3	0	.	p	.	0	D218N	NONSYN	652	654	GAT	241	243	AAT	5;5;5	A;A;T	5;5;4	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	78	porB1a	984	181	90.27	porB1a.l6.c4.ctg.2	394	5.3	0	.	p	.	0	A222V	NONSYN	664	666	GCT	253	255	GTT	5;5;5	G;T;T	5;5;5	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	78	porB1a	984	181	90.27	porB1a.l6.c4.ctg.2	394	5.3	0	.	p	.	0	V226A	NONSYN	676	678	GTA	265	267	GCA	5;5;5	G;C;A	5;5;5	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	78	porB1a	984	181	90.27	porB1a.l6.c4.ctg.2	394	5.3	0	.	p	.	0	.	MULTIPLE	700	702	ACT	288	290	GTA	7;7;7	G;T;A	4;5;5	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	78	porB1a	984	181	90.27	porB1a.l6.c4.ctg.2	394	5.3	0	.	p	.	0	N237fs	FSHIFT	709	709	A	297	297	A	7	A	5	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	806	porB1b	1047	1047	98.19	porB1b.l15.c17.ctg.1	1671	139.7	0	.	p	.	0	T18M	NONSYN	52	54	ACG	365	367	ATG	143;143;144	A;T,C;G	121;124,1;121	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	806	porB1b	1047	1047	98.19	porB1b.l15.c17.ctg.1	1671	139.7	0	.	p	.	0	K143Q	NONSYN	427	429	AAA	740	742	CAA	148;148;148	C,A;A,G;A	125,1;125,1;125	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	806	porB1b	1047	1047	98.19	porB1b.l15.c17.ctg.1	1671	139.7	0	.	p	.	0	E212del	DEL	634	634	G	947	947	G	163	G	138	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	806	porB1b	1047	1047	98.19	porB1b.l15.c17.ctg.1	1671	139.7	0	.	p	.	0	Q214del	DEL	640	640	C	949	949	T	161	T	140	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	806	porB1b	1047	1047	98.19	porB1b.l15.c17.ctg.1	1671	139.7	0	.	p	.	0	V215D	NONSYN	643	645	GTT	950	952	GAT	159;158;157	G;A;T	139;136;137	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	806	porB1b	1047	1047	98.19	porB1b.l15.c17.ctg.1	1671	139.7	0	.	p	.	0	I218T	NONSYN	652	654	ATC	959	961	ACC	154;154;154	A;C;C	135;133;134	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	806	porB1b	1047	1047	98.19	porB1b.l15.c17.ctg.1	1671	139.7	0	.	p	.	0	R257M	NONSYN	769	771	AGG	1076	1078	ATG	192;191;190	A;T;G	159;156;156	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	806	porB1b	1047	1047	98.19	porB1b.l15.c17.ctg.1	1671	139.7	0	.	p	.	0	R258S	NONSYN	772	774	AGG	1079	1081	AGC	189;189;189	A;G;C,A	156;157;154,1	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	806	porB1b	1047	1047	98.19	porB1b.l15.c17.ctg.1	1671	139.7	0	.	p	.	0	A259G	NONSYN	775	777	GCT	1082	1084	GGT	189;189;189	G;G;T	158;157;156	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	806	porB1b	1047	1047	98.19	porB1b.l15.c17.ctg.1	1671	139.7	0	.	p	.	0	D297N	NONSYN	889	891	GAC	1196	1198	AAC	190;191;191	A;A;C,A	166;167;164,1	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	806	porB1b	1047	1047	98.19	porB1b.l15.c17.ctg.1	1671	139.7	1	SNP	p	G120K	0	.	.	358	360	GGC	671	673	GGC	150;149;149	G;G;C,T	130;128;126,1	porB1b.WHO_P_02204c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	539	2734	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5236	156.6	0	.	p	.	0	A998V	NONSYN	2992	2994	GCA	3516	3518	GTA	177;176;178	G;T;A	153;152;154	.	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	539	2734	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5236	156.6	1	SNP	p	H553N	0	.	.	1657	1659	CAT	2181	2183	CAT	160;159;161	C,T;A;T	141,1;141;140	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_F_02142c	rpsJ.WHO_F_02142c	1	1	27	416	rpsJ	312	312	100.0	rpsJ.l6.c17.ctg.1	1250	99.8	1	SNP	p	V57M	0	.	.	169	171	GTG	638	640	GTG	164;164;165	G,A;T;G	145,1;146;146	rpsJ.WHO_F_02142c:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
